X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
melanoma (19) 19
oncology (18) 18
index medicus (15) 15
female (12) 12
adult (11) 11
male (11) 11
melanoma - drug therapy (10) 10
metastasis (10) 10
middle aged (10) 10
skin cancer (10) 10
malignant-melanoma (9) 9
aged (8) 8
chemotherapy (8) 8
further section (7) 7
immunotherapy (7) 7
metastases (7) 7
patients (7) 7
skin (7) 7
survival (7) 7
cancer (6) 6
melanoma - pathology (6) 6
radiotherapy (6) 6
apoptosis (5) 5
dermatology (5) 5
medicine & public health (5) 5
nivolumab (5) 5
skin neoplasms - drug therapy (5) 5
skin neoplasms - pathology (5) 5
treatment outcome (5) 5
activation (4) 4
aged, 80 and over (4) 4
antineoplastic agents - therapeutic use (4) 4
cell biology (4) 4
ctla-4 protein (4) 4
ipilimumab (4) 4
melanoma - secondary (4) 4
metastatic melanoma (4) 4
pembrolizumab (4) 4
analysis (3) 3
antigens (3) 3
biochemistry & molecular biology (3) 3
care and treatment (3) 3
cd8-positive t-lymphocytes - immunology (3) 3
cerebral metastases (3) 3
cutaneous melanoma (3) 3
cytokines (3) 3
dabrafenib (3) 3
expression (3) 3
gene expression (3) 3
growth (3) 3
immune checkpoint (3) 3
immunohistochemistry (3) 3
immunology (3) 3
in-vitro (3) 3
inhibition (3) 3
medical research (3) 3
medical services (3) 3
melanoma - mortality (3) 3
multivariate analysis (3) 3
mutation (3) 3
patient outcomes (3) 3
pd-1 protein (3) 3
prognosis (3) 3
radiation (3) 3
resistance (3) 3
skin neoplasms - mortality (3) 3
surgery (3) 3
survival analysis (3) 3
therapy (3) 3
vemurafenib (3) 3
amino acid sequence (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
atopic-dermatitis (2) 2
biopsy (2) 2
blood (2) 2
braf (2) 2
brain (2) 2
brain metastases (2) 2
brain neoplasms - secondary (2) 2
cancer research (2) 2
cd8-positive t-lymphocytes - metabolism (2) 2
clinical neurology (2) 2
clinical study (2) 2
clinical trials (2) 2
combined modality therapy (2) 2
confidence intervals (2) 2
ctla-4 antigen - antagonists & inhibitors (2) 2
ctla-4 blockade (2) 2
cytomegalovirus (2) 2
cytotoxicity (2) 2
dacarbazine (2) 2
dendritic cells (2) 2
diagnosis (2) 2
diagnosis, differential (2) 2
disease progression (2) 2
dose-response relationship, drug (2) 2
drug therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE MEDICINE, ISSN 1078-8956, 12/2019, Volume 25, Issue 12, pp. 1916 - 1916
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 02/2019, Volume 58, Issue 2, pp. 258 - 269
Melanoma represents a prime example demonstrating the success of targeted therapy in cancer. Nevertheless, it remained a deadly disease until now, and the... 
apoptosis | kinase pathway | melanoma | stat 3 | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CYCLE ARREST | DEATH | MALIGNANT-MELANOMA | INDUCE APOPTOSIS | CANCER | IN-VITRO | INHIBITION | ONCOLOGY | GROWTH | RESISTANCE | p53 Protein | Melanoma | Caspase | XIAP protein | Dephosphorylation | Antioxidants | Signaling | Mitochondria | Molecular modelling | Tumor necrosis factor | TRAIL protein | Membrane potential | Pretreatment | Viability | Apoptosis | Cancer
Journal Article
Journal Article
Journal Article
Current Opinion in Allergy and Clinical Immunology, ISSN 1528-4050, 10/2016, Volume 16, Issue 5, pp. 451 - 457
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2018, Volume 118, Issue 6, pp. 785 - 792
Background: Concomitant radiation with BRAF inhibitor (BRAFi) therapy may increase radiation-induced side effects but also potentially improve tumour control... 
Dabrafenib | Vemurafenib | BRAF | Radiotherapy | Radiation | MECHANISM | ONCOLOGY | radiation | CYSTS | METASTASES | radiotherapy | vemurafenib | TOXICITY | CUTIS-VERTICIS-GYRATA | dabrafenib | RECHALLENGE | Index Medicus | Clinical Study
Journal Article
Der Onkologe, ISSN 0947-8965, 6/2018, Volume 24, Issue 6, pp. 453 - 463
Das maligne Melanom ist eine häufige Hautkrebsart mit einer sehr hohen Mortalität. In Europa versterben jährlich etwa 22.000 Menschen daran, davon etwa 2700... 
Hautkrebs | Immunosuppression | Medicine & Public Health | Melanozytäre Nävi | Immunsuppression | Wächterlymphknoten | Sentinel lymph node | Melanocytic naevi | Oncology | Krebs | Skin cancer | Cancer
Journal Article
Onkologe, ISSN 0947-8965, 06/2018, Volume 24, Issue 6, pp. 453 - 463
Journal Article
Der Onkologe, ISSN 0947-8965, 06/2018, Volume 24, Issue 6, p. 453
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00761-018-0379-y... 
Immunotherapy | Melanoma | Skin | Skin cancer
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 82, pp. 56 - 65
Journal Article